direct thrombin inhibitors prevent left atrial remodeling associated with heart failure in rats
Clicks: 240
ID: 183387
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
240 views
27 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #16 of 42 articles by views in journal of nuclear materials
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The present study tested the hypothesis that thrombin participates in formation of left atrial remodeling and that direct oral anticoagulants, such as direct thrombin inhibitors (DTIs), can prevent its progression. In a rat model of heart failure associated with left atrial dilation, we found that chronic treatment with DTIs reduces the atrial remodeling and the duration of atrial fibrillation (AF) episodes induced by burst pacing by inhibiting myocardial hypertrophy and fibrosis. In addition to the prevention of thromboembolism complicating AF, DTIs may be of interest to slow down the progression of the arrhythmogenic substrate.
| Reference Key |
phd2016jacc:direct
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Céline Jumeau, PharmD, PhD;Alain Rupin, PharmD, PhD;Pauline Chieng-Yane, PhD;Nathalie Mougenot, PhD;Noël Zahr, PharmD, PhD;Monique David-Dufilho, PhD;Stéphane N. Hatem, MD, PhD |
| Journal | journal of nuclear materials |
| Year | 2016 |
| DOI |
10.1016/j.jacbts.2016.05.002
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.